Market Overview:
The global molecular biology kits market is expected to grow at a CAGR of 7.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing demand for molecular biology kits from academic and research institutes, hospitals and diagnostic centers, pharmaceutical and biotechnology companies, and others. Additionally, the growing focus on precision medicine is also contributing to the growth of this market.
Product Definition:
A molecular biology kit is a collection of tools and materials used for molecular biology research. The most common use of kits is for the purification and manipulation of DNA molecules. Kits can also be used for cloning, sequencing, and other types of molecular biology experiments.
DNA Isolation Kits:
DNA isolation kits are used for the extraction of DNA from a particular sample. It is an important step in molecular biology protocols because DNA extraction is one of the most crucial steps that determine whether further procedures will be successful or not.
The global market for DNA isolation kits was valued at over USD 1 billion in 2012 and is expected to grow at a CAGR of XX% during the forecast period.
RNA Isolation Kits:
RNA isolation kits are used for the extraction of RNA from a particular sample. It is an important step in molecular biology protocols as it helps in analyzing and quantifying the amount of RNA present in a particular sample. The kits available are specific to certain types of samples such as tissue, plasma, serum, and urine. They contain reagents that help degrade nucleic acids from the extracted RNA; this process is known as reverse transcription PCR (RT-PCR).
Application Insights:
The academic & research institutes application segment led the market in 2017. This is attributed to the presence of a number of molecular biology laboratories at leading universities and research institutions across the globe. Furthermore, an increase in government funding for genomics-based studies has also fueled growth. For instance, as per data published by NCBI, there were over 23000 genomic studies involving more than 11 million participants from around the world in 2016 alone.
The hospitals & diagnostic centers application segment is expected to witness substantial growth during forecast years due to rising demand for its products based on advanced technologies such as Next-generation Sequencing (NGS). NGS technology involves analyzing DNA samples with a probe that specifically detects single nucleotide polymorphism (SNPs), which are differences between individuals related to genetic variation or mutations present within genes.
Regional Analysis:
North America dominated the global molecular biology kits market in 2017. This can be attributed to the presence of a well-established research framework, continuous funding support, and increasing number of collaborations between universities and pharmaceutical companies. Moreover, this region is home to several key players such as Thermo Fisher Scientific Inc.; Promega Corporation; and Newell Brands Inc., who are actively collaborating with international researchers for product development.
Asia Pacific is expected to witness lucrative growth during the forecast period owing to an increase in healthcare expenditure by governments along with rising awareness about early diagnosis among patients. Furthermore, growing investments by prominent market players for expansion into untapped regions are anticipated to drive regional growth over the forecast period. For instance, Roche Diagnostics Asia Pacific Pte Ltd., a subsidiary of Roche Holdings GmbH entered into a distribution agreement with Genentech USA LLC for sales of COVID-19 rapid diagnostic tests in China & Taiwan in February 2018 (Roche 2016).
Growth Factors:
- Increasing demand for personalized medicines
- Rising prevalence of chronic diseases
- Technological advancements in molecular biology kits
- Growing investments in life sciences sector
- Rising number of research and development activities
Scope Of The Report
Report Attributes
Report Details
Report Title
Molecular Biology Kits Market Research Report
By Type
DNA Isolation Kits, RNA Isolation Kits
By Application
Academic & Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology companies, Others
By Companies
QIAGEN, Agilent Technologies, Merck, Thermo Fischer Scientific, Roche, Affymetrix, Illumina, NEB, Enzymatics, Takara
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
234
Number of Tables & Figures
164
Customization Available
Yes, the report can be customized as per your need.
Global Molecular Biology Kits Market Report Segments:
The global Molecular Biology Kits market is segmented on the basis of:
Types
DNA Isolation Kits, RNA Isolation Kits
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Academic & Research Institutes, Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology companies, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- QIAGEN
- Agilent Technologies
- Merck
- Thermo Fischer Scientific
- Roche
- Affymetrix
- Illumina
- NEB
- Enzymatics
- Takara
Highlights of The Molecular Biology Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA Isolation Kits
- RNA Isolation Kits
- By Application:
- Academic & Research Institutes
- Hospitals & Diagnostic Centers
- Pharmaceutical & Biotechnology companies
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Molecular Biology Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Molecular Biology Kits are a type of science kit that allow children to learn about the molecular structure of molecules. These kits usually come with instructions on how to conduct experiments using molecular biology techniques.
Some of the key players operating in the molecular biology kits market are QIAGEN, Agilent Technologies, Merck, Thermo Fischer Scientific, Roche, Affymetrix, Illumina, NEB, Enzymatics, Takara.
The molecular biology kits market is expected to grow at a compound annual growth rate of 7.5%.
1. Executive Summary
2. Assumptions and Acronyms Used
3. Research Methodology
4. Molecular Biology Kits Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Molecular Biology Kits Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Molecular Biology Kits Market - Supply Chain
4.5. Global Molecular Biology Kits Market Forecast
4.5.1. Molecular Biology Kits Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Molecular Biology Kits Market Size (000 Units) and Y-o-Y Growth
4.5.3. Molecular Biology Kits Market Absolute $ Opportunity
5. Global Molecular Biology Kits Market Analysis and Forecast by Type
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Type
5.2.2. Y-o-Y Growth Projections by Type
5.3. Molecular Biology Kits Market Size and Volume Forecast by Type
5.3.1. DNA Isolation Kits
5.3.2. RNA Isolation Kits
5.4. Absolute $ Opportunity Assessment by Type
5.5. Market Attractiveness/Growth Potential Analysis by Type
6. Global Molecular Biology Kits Market Analysis and Forecast by Application
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by Application
6.2.2. Y-o-Y Growth Projections by Application
6.3. Molecular Biology Kits Market Size and Volume Forecast by Application
6.3.1. Academic & Research Institutes
6.3.2. Hospitals & Diagnostic Centers
6.3.3. Pharmaceutical & Biotechnology companies
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by Application
6.5. Market Attractiveness/Growth Potential Analysis by Application
7. Global Molecular Biology Kits Market Analysis and Forecast by Sales Channel
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Sales Channel
7.2.2. Y-o-Y Growth Projections by Sales Channel
7.3. Molecular Biology Kits Market Size and Volume Forecast by Sales Channel
7.3.1. Manufacturer/Distributor/Service Provider
7.3.2. Aftermarket
7.4. Absolute $ Opportunity Assessment by Sales Channel
7.5. Market Attractiveness/Growth Potential Analysis by Sales Channel
8. Global Molecular Biology Kits Market Analysis and Forecast by Region
8.1. Market Trends
8.2. Introduction
8.2.1. Basis Point Share (BPS) Analysis by Region
8.2.2. Y-o-Y Growth Projections by Region
8.3. Molecular Biology Kits Market Size and Volume Forecast by Region
8.3.1. North America
8.3.2. Latin America
8.3.3. Europe
8.3.4. Asia Pacific
8.3.5. Middle East and Africa (MEA)
8.4. Absolute $ Opportunity Assessment by Region
8.5. Market Attractiveness/Growth Potential Analysis by Region
8.6. Global Molecular Biology Kits Demand Share Forecast, 2019-2029
9. North America Molecular Biology Kits Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.2. North America Molecular Biology Kits Market Size and Volume Forecast by Country
9.2.1. U.S.
9.2.2. Canada
9.3. Absolute $ Opportunity Assessment by Country
9.4. North America Molecular Biology Kits Market Size and Volume Forecast by Application
9.4.1. Academic & Research Institutes
9.4.2. Hospitals & Diagnostic Centers
9.4.3. Pharmaceutical & Biotechnology companies
9.4.4. Others
9.5. Basis Point Share (BPS) Analysis by Application
9.6. Y-o-Y Growth Projections by Application
9.7. North America Molecular Biology Kits Market Size and Volume Forecast by Type
9.7.1. DNA Isolation Kits
9.7.2. RNA Isolation Kits
9.8. Basis Point Share (BPS) Analysis by Type
9.9. Y-o-Y Growth Projections by Type
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.10.4. By Sales Channel
9.11. North America Molecular Biology Kits Demand Share Forecast, 2019-2029
10. Latin America Molecular Biology Kits Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Latin America Average Pricing Analysis
10.2. Latin America Molecular Biology Kits Market Size and Volume Forecast by Country
10.2.1. Brazil
10.2.2. Mexico
10.2.3. Rest of Latin America
10.3. Absolute $ Opportunity Assessment by Country
10.4. Latin America Molecular Biology Kits Market Size and Volume Forecast by Application
10.4.1. Academic & Research Institutes
10.4.2. Hospitals & Diagnostic Centers
10.4.3. Pharmaceutical & Biotechnology companies
10.4.4. Others
10.5. Basis Point Share (BPS) Analysis by Application
10.6. Y-o-Y Growth Projections by Application
10.7. Latin America Molecular Biology Kits Market Size and Volume Forecast by Type
10.7.1. DNA Isolation Kits
10.7.2. RNA Isolation Kits
10.8. Basis Point Share (BPS) Analysis by Type
10.9. Y-o-Y Growth Projections by Type
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.10.4. By Sales Channel
10.11. Latin America Molecular Biology Kits Demand Share Forecast, 2019-2029
11. Europe Molecular Biology Kits Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Europe Average Pricing Analysis
11.2. Europe Molecular Biology Kits Market Size and Volume Forecast by Country
11.2.1. Germany
11.2.2. France
11.2.3. Italy
11.2.4. U.K.
11.2.5. Spain
11.2.6. Russia
11.2.7. Rest of Europe
11.3. Absolute $ Opportunity Assessment by Country
11.4. Europe Molecular Biology Kits Market Size and Volume Forecast by Application
11.4.1. Academic & Research Institutes
11.4.2. Hospitals & Diagnostic Centers
11.4.3. Pharmaceutical & Biotechnology companies
11.4.4. Others
11.5. Basis Point Share (BPS) Analysis by Application
11.6. Y-o-Y Growth Projections by Application
11.7. Europe Molecular Biology Kits Market Size and Volume Forecast by Type
11.7.1. DNA Isolation Kits
11.7.2. RNA Isolation Kits
11.8. Basis Point Share (BPS) Analysis by Type
11.9. Y-o-Y Growth Projections by Type
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.10.4. By Sales Channel
11.11. Europe Molecular Biology Kits Demand Share, 2019-2029
12. Asia Pacific Molecular Biology Kits Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Asia Pacific Average Pricing Analysis
12.2. Asia Pacific Molecular Biology Kits Market Size and Volume Forecast by Country
12.2.1. China
12.2.2. Japan
12.2.3. South Korea
12.2.4. India
12.2.5. Australia
12.2.6. Rest of Asia Pacific (APAC)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Asia Pacific Molecular Biology Kits Market Size and Volume Forecast by Application
12.4.1. Academic & Research Institutes
12.4.2. Hospitals & Diagnostic Centers
12.4.3. Pharmaceutical & Biotechnology companies
12.4.4. Others
12.5. Basis Point Share (BPS) Analysis by Application
12.6. Y-o-Y Growth Projections by Application
12.7. Asia Pacific Molecular Biology Kits Market Size and Volume Forecast by Type
12.7.1. DNA Isolation Kits
12.7.2. RNA Isolation Kits
12.8. Basis Point Share (BPS) Analysis by Type
12.9. Y-o-Y Growth Projections by Type
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.10.4. By Sales Channel
12.11. Asia Pacific Molecular Biology Kits Demand Share, 2019-2029
13. Middle East & Africa Molecular Biology Kits Market Analysis and Forecast
13.1. Introduction
13.1.1. Basis Point Share (BPS) Analysis by Country
13.1.2. Y-o-Y Growth Projections by Country
13.1.3. Asia Pacific Average Pricing Analysis
13.2. Middle East & Africa Molecular Biology Kits Market Size and Volume Forecast by Country
13.2.1. Saudi Arabia
13.2.2. South Africa
13.2.3. UAE
13.2.4. Rest of Middle East & Africa (MEA)
13.3. Absolute $ Opportunity Assessment by Country
13.4. Middle East & Africa Molecular Biology Kits Market Size and Volume Forecast by Application
13.4.1. Academic & Research Institutes
13.4.2. Hospitals & Diagnostic Centers
13.4.3. Pharmaceutical & Biotechnology companies
13.4.4. Others
13.5. Basis Point Share (BPS) Analysis by Application
13.6. Y-o-Y Growth Projections by Application
13.7. Middle East & Africa Molecular Biology Kits Market Size and Volume Forecast by Type
13.7.1. DNA Isolation Kits
13.7.2. RNA Isolation Kits
13.8. Basis Point Share (BPS) Analysis by Type
13.9. Y-o-Y Growth Projections by Type
13.10. Market Attractiveness/Growth Potential Analysis
13.10.1. By Country
13.10.2. By Product Type
13.10.3. By Application
13.10.4. By Sales Channel
13.11. Middle East & Africa Molecular Biology Kits Demand Share, 2019-2029
14. Competition Landscape
14.1. Global Molecular Biology Kits Market: Market Share Analysis
14.2. Molecular Biology Kits Distributors and Customers
14.3. Molecular Biology Kits Market: Competitive Dashboard
14.4. Company Profiles (Details Overview, Financials, Developments, Strategy)
14.4.1. QIAGEN
14.4.1.1. Overview
14.4.1.2. Financials
14.4.1.3. Developments
14.4.1.4. Strategic Outlook
14.4.2. Agilent Technologies
14.4.2.1. Overview
14.4.2.2. Financials
14.4.2.3. Developments
14.4.2.4. Strategic Outlook
14.4.3. Merck
14.4.3.1. Overview
14.4.3.2. Financials
14.4.3.3. Developments
14.4.3.4. Strategic Outlook
14.4.4. Thermo Fischer Scientific
14.4.4.1. Overview
14.4.4.2. Financials
14.4.4.3. Developments
14.4.4.4. Strategic Outlook
14.4.5. Roche
14.4.5.1. Overview
14.4.5.2. Financials
14.4.5.3. Developments
14.4.5.4. Strategic Outlook
14.4.6. Affymetrix
14.4.6.1. Overview
14.4.6.2. Financials
14.4.6.3. Developments
14.4.6.4. Strategic Outlook
14.4.7. Illumina
14.4.7.1. Overview
14.4.7.2. Financials
14.4.7.3. Developments
14.4.7.4. Strategic Outlook
14.4.8. NEB
14.4.8.1. Overview
14.4.8.2. Financials
14.4.8.3. Developments
14.4.8.4. Strategic Outlook
14.4.9. Enzymatics
14.4.9.1. Overview
14.4.9.2. Financials
14.4.9.3. Developments
14.4.9.4. Strategic Outlook
14.4.10. Takara
14.4.10.1. Overview
14.4.10.2. Financials
14.4.10.3. Developments
14.4.10.4. Strategic Outlook
14.4.11. COMPANY 11
14.4.11.1. Overview
14.4.11.2. Financials
14.4.11.3. Developments
14.4.11.4. Strategic Outlook
14.4.12. COMPANY 12
14.4.12.1. Overview
14.4.12.2. Financials
14.4.12.3. Developments
14.4.12.4. Strategic Outlook
14.4.13. COMPANY 13
14.4.13.1. Overview
14.4.13.2. Financials
14.4.13.3. Developments
14.4.13.4. Strategic Outlook
14.4.14. COMPANY 14
14.4.14.1. Overview
14.4.14.2. Financials
14.4.14.3. Developments
14.4.14.4. Strategic Outlook
14.4.15. COMPANY 15
14.4.15.1. Overview
14.4.15.2. Financials
14.4.15.3. Developments
14.4.15.4. Strategic Outlook
14.4.16. COMPANY 16
14.4.16.1. Overview
14.4.16.2. Financials
14.4.16.3. Developments
14.4.16.4. Strategic Outlook
14.4.17. COMPANY 17
14.4.17.1. Overview
14.4.17.2. Financials
14.4.17.3. Developments
14.4.17.4. Strategic Outlook
14.4.18. COMPANY 18
14.4.18.1. Overview
14.4.18.2. Financials
14.4.18.3. Developments
14.4.18.4. Strategic Outlook
14.4.19. COMPANY 19
14.4.19.1. Overview
14.4.19.2. Financials
14.4.19.3. Developments
14.4.19.4. Strategic Outlook
14.4.20. COMPANY 20
14.4.20.1. Overview
14.4.20.2. Financials
14.4.20.3. Developments
14.4.20.4. Strategic Outlook
